Compare IPSC & FCBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | FCBM |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | |
| Employees | 78 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.6M | 393.3M |
| IPO Year | 2021 | 2026 |
| Metric | IPSC | FCBM |
|---|---|---|
| Price | $1.92 | $12.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.25 | N/A |
| AVG Volume (30 Days) | ★ 386.4K | 84.0K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.70 |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $12.17 |
| 52 Week High | $2.97 | $13.40 |
| Indicator | IPSC | FCBM |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 58.50 |
| Support Level | $1.92 | $12.50 |
| Resistance Level | $2.39 | $12.92 |
| Average True Range (ATR) | 0.10 | 0.24 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 7.35 | 77.08 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
First Carolina Financial Services Inc is a bank holding company. The company's activities consist of managing and owning the Bank and its direct and indirect subsidiaries. The Bank provides commercial banking, payment, consumer banking, and wealth management services to small and medium-sized businesses, individuals, professionals, as well as institutions of higher education. It has four primary lines of business: Commercial Banking, Payments, Consumer Banking and Wealth Management. The reportable segments are Community Banking and BM Tech. The majority of revenue is derived from the Community Banking segment, which comprises activities of a traditional banking institution, gathering deposits and originating loans for portfolio in its respective primary market areas.